A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non–Small-Cell Lung Cancer
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer January 2017 18(1):e41-e47 - Subject
- Language
- ISSN
- 1525-7304